{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:13:45Z","timestamp":1782742425009,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.antiviral.2020.104719","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T02:28:12Z","timestamp":1580178492000},"page":"104719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients"],"prefix":"10.1016","volume":"176","author":[{"given":"Wen-Chun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Chin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Cheng","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chih","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chih","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Nan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Tsung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104719_bib1","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.1111\/j.1365-2893.2010.01414.x","article-title":"A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study","volume":"18","author":"Akkiz","year":"2011","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2020.104719_bib2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ni0503-432","article-title":"Linking Toll-like receptors to IFN-alpha\/beta expression","volume":"4","author":"Barton","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2020.104719_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/BJ20051659","article-title":"TNFalpha- and IKKbeta-mediated TANK\/I-TRAF phosphorylation: implications for interaction with NEMO\/IKKgamma and NF-kappaB activation","volume":"394","author":"Bonif","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2020.104719_bib4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0140-6736(89)90713-7","article-title":"Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection","volume":"2","author":"Carman","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104719_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.antiviral.2020.104719_bib6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1440-1746.2006.04304.x","article-title":"Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms","volume":"21","author":"Cheong","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104719_bib7","series-title":"Chronic Hepatitis B and C: Basic Science to Clinical Applications","author":"Chiaho","year":"2012"},{"key":"10.1016\/j.antiviral.2020.104719_bib8","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1128\/MCB.19.10.6665","article-title":"TANK potentiates tumor necrosis factor receptor-associated factor-mediated c-Jun N-terminal kinase\/stress-activated protein kinase activation through the germinal center kinase pathway","volume":"19","author":"Chin","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2020.104719_bib9","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/gast.2002.33588","article-title":"Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.","volume":"122","author":"Chu","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104719_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2893.2006.00810.x","article-title":"Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion","volume":"14","author":"Chu","year":"2007","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2020.104719_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2018.11.037","article-title":"New and old biomarkers for diagnosis and management of chronic hepatitis B virus infection","volume":"156","author":"Coffin","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104719_bib12","doi-asserted-by":"crossref","first-page":"10395","DOI":"10.3748\/wjg.v20.i30.10395","article-title":"Natural history of chronic hepatitis B: phases in a complex relationship","volume":"20","author":"Croagh","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2020.104719_bib13","doi-asserted-by":"crossref","first-page":"e37786","DOI":"10.5812\/hepatmon.37786","article-title":"Host genetic variants in HLA loci influence risk for hepatitis B virus infection in children","volume":"16","author":"Fan","year":"2016","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.antiviral.2020.104719_bib14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gut.2007.128496","article-title":"Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years","volume":"57","author":"Fattovich","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2020.104719_bib15","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/jmv.24225","article-title":"IL-18, TNF, and IFN-gamma alleles and genotypes are associated with susceptibility to chronic hepatitis B infection and severity of liver injury","volume":"87","author":"Ferreira Sda","year":"2015","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2020.104719_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/v9100304","article-title":"Hepatitis B virus and DNA damage response: interactions and consequences for the infection","volume":"9","author":"Gomez-Moreno","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104719_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00439-009-0750-6","article-title":"An intronic polymorphism in the corticotropin-releasing hormone receptor 2 gene increases susceptibility to HBV-related hepatocellular carcinoma in Chinese population","volume":"127","author":"Gu","year":"2010","journal-title":"Hum. Genet."},{"key":"10.1016\/j.antiviral.2020.104719_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11033-011-0801-7","article-title":"An intronic polymorphism rs2237062 in the CXCL14 gene influences HBV-related HCC progression in Chinese population","volume":"39","author":"Gu","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.antiviral.2020.104719_bib19","doi-asserted-by":"crossref","first-page":"11817","DOI":"10.1074\/jbc.M700017200","article-title":"Modulation of the interferon antiviral response by the TBK1\/IKKi adaptor protein TANK","volume":"282","author":"Guo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104719_bib20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.24048","article-title":"Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population","volume":"53","author":"Guo","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104719_bib21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/jhep.2001.27834","article-title":"Hepatitis B e antigen-negative chronic hepatitis B","volume":"34","author":"Hadziyannis","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104719_bib22","doi-asserted-by":"crossref","first-page":"e1898","DOI":"10.1371\/journal.pone.0001898","article-title":"Host genetic factors and vaccine-induced immunity to hepatitis B virus infection","volume":"3","author":"Hennig","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104719_bib23","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/jhep.2002.33638","article-title":"Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B","volume":"35","author":"Hsu","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104719_bib24","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.24799","article-title":"Genetic variants in human leukocyte antigen\/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development","volume":"55","author":"Hu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104719_bib25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3851\/IMP2630","article-title":"Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy","volume":"18","author":"Huang","year":"2013","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2020.104719_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/hep.21724","article-title":"Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase","volume":"46","author":"Hui","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104719_bib27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1053\/he.2000.6709","article-title":"Clinical relevance of hepatitis B viral mutations","volume":"31","author":"Hunt","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104719_bib28","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104719_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.humimm.2009.09.352","article-title":"Association of an NKG2D gene variant with systemic lupus erythematosus in two populations","volume":"71","author":"Kabalak","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.antiviral.2020.104719_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cyto.2015.02.015","article-title":"IL-18 polymorphisms in hepatitis B virus related liver disease","volume":"73","author":"Karra","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.antiviral.2020.104719_bib31","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ni.1771","article-title":"TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis","volume":"10","author":"Kawagoe","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2020.104719_bib32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1186\/1756-0500-7-789","article-title":"Association between single-nucleotide polymorphisms and early spontaneous hepatitis B virus e antigen seroconversion in children","volume":"7","author":"Komatsu","year":"2014","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.antiviral.2020.104719_bib33","first-page":"953","article-title":"Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinoma","volume":"10","author":"Liao","year":"2018","journal-title":"Canc. Manag. Res."},{"key":"10.1016\/j.antiviral.2020.104719_bib34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cld.2019.04.002","article-title":"Understanding the natural history of hepatitis B virus infection and the new definitions of cure and the endpoints of clinical trials","volume":"23","author":"Likhitsup","year":"2019","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.antiviral.2020.104719_bib35","doi-asserted-by":"crossref","first-page":"e91658","DOI":"10.1371\/journal.pone.0091658","article-title":"Hepatitis B virus polymerase suppresses NF-kappaB signaling by inhibiting the activity of IKKs via interaction with Hsp90beta","volume":"9","author":"Liu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104719_bib36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/path.4938","article-title":"Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus","volume":"243","author":"Liu","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.antiviral.2020.104719_bib37","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/jmv.21855","article-title":"Association of NKG2D genetic polymorphism with susceptibility to chronic hepatitis B in a Han Chinese population","volume":"82","author":"Ma","year":"2010","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2020.104719_bib38","volume":"vol. 6","author":"Ma","year":"2018"},{"key":"10.1016\/j.antiviral.2020.104719_bib39","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/ng1007-1181","article-title":"The NCBI dbGaP database of genotypes and phenotypes","volume":"39","author":"Mailman","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.antiviral.2020.104719_bib40","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1093\/hmg\/ddr301","article-title":"A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population","volume":"20","author":"Mbarek","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.antiviral.2020.104719_bib41","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1053\/jhep.2003.50453","article-title":"Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection","volume":"38","author":"Milich","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104719_bib42","doi-asserted-by":"crossref","first-page":"24767","DOI":"10.1038\/srep24767","article-title":"Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis","volume":"6","author":"Nishida","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104719_bib43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fimmu.2017.00313","article-title":"The impact of the interferon\/TNF-related apoptosis-inducing ligand signaling Axis on disease progression in respiratory viral infection and beyond","volume":"8","author":"Peteranderl","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2020.104719_bib44","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s11033-011-0868-1","article-title":"Prevalence of the NKG2D Thr72Ala polymorphism in patients with systemic lupus erythematosus","volume":"39","author":"Piotrowski","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.antiviral.2020.104719_bib45","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.humimm.2010.02.017","article-title":"Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection","volume":"71","author":"Qi","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.antiviral.2020.104719_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40001-017-0288-3","article-title":"Advances in the genome-wide association study of chronic hepatitis B susceptibility in Asian population","volume":"22","author":"Qiu","year":"2017","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.antiviral.2020.104719_bib47","doi-asserted-by":"crossref","first-page":"e12273","DOI":"10.1371\/journal.pone.0012273","article-title":"Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis","volume":"5","author":"Ryckman","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104719_bib48","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1038\/sj.emboj.7601743","article-title":"SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK","volume":"26","author":"Ryzhakov","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2020.104719_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/vim.2011.0053","article-title":"Association of a TANK gene polymorphism with outcomes of hepatitis B virus infection in a Chinese Han population","volume":"25","author":"Song","year":"2012","journal-title":"Viral Immunol."},{"key":"10.1016\/j.antiviral.2020.104719_bib50","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104719_bib51","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Trepo","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104719_bib52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1744-313X.2008.00770.x","article-title":"Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome","volume":"35","author":"Truelove","year":"2008","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.antiviral.2020.104719_bib53","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/hep.21482","article-title":"Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein","volume":"45","author":"Visvanathan","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104719_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9069375","article-title":"Clinical relevance of HLA gene variants in HBV infection","author":"Wang","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.antiviral.2020.104719_bib55","doi-asserted-by":"crossref","first-page":"13372","DOI":"10.1074\/jbc.M115.643767","article-title":"TRAF family member-associated NF-kappaB activator (TANK) inhibits genotoxic nuclear factor kappaB activation by facilitating deubiquitinase USP10-dependent deubiquitination of TRAF6 ligase","volume":"290","author":"Wang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104719_bib56","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.22751","article-title":"Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells","volume":"49","author":"Wu","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104719_bib57","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJMoa013215","article-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma","volume":"347","author":"Yang","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104719_bib58","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/mc.20805","article-title":"Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma","volume":"51","author":"Yang","year":"2012","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.antiviral.2020.104719_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019406","article-title":"Association between human leucocyte antigen-DO polymorphisms and interferon\/ribavirin treatment response in hepatitis C virus type 1 infection in Chinese population: a prospective study","author":"Yao","year":"2018","journal-title":"BMJ Open 8"},{"key":"10.1016\/j.antiviral.2020.104719_bib60","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1099\/vir.0.020552-0","volume":"91","author":"Yu","year":"2010","journal-title":"J. Gen. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:20Z","timestamp":1759062740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219304346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":60,"alternative-id":["S0166354219304346"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104719","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104719"}}